Skip to content
Open access

Repositioning of polyubiquitin alters the pathologic tau filament structure.

Aug 2026 · Nature Structural & Molecular Biology · 0 citations · 28 references
Medicine

TL;DR

It is found that polyubiquitinated tau filaments from Alzheimer disease and vacuolar tauopathy human brain tissue exhibit distinct seeding patterns in mice, in association with differences in tau filament ultrastructure determined by cryo-electron microscopy.

Abstract

Structurally diverse tau filaments form proteinaceous aggregates in a heterogeneous group of neurodegenerative diseases called tauopathies. The factors extrinsic to the highly ordered core structure that influence tau filament stability are not well understood. Here, we found that polyubiquitinated tau filaments from Alzheimer disease and vacuolar tauopathy human brain tissue exhibit distinct seeding patterns in mice, in association with differences in tau filament ultrastructure determined by cryo-electron microscopy. Chemical modulation of the polarity of polyubiquitin adjacent to the tau core with the small molecule ubistatin B resulted in the repositioning of poorly structured densities toward positively charged residues on the highly structured core filament, leading to shifting of the protofilament-protofilament interface of certain vacuolar tauopathy tau filaments. These results suggest that the structure of tau filaments that are associated with different seeding activities in vivo can be influenced by post-translational modifications.

Read PDF

Similar papers

Open access Aug 2026

Cofactor-Free Tau Filaments Are Dynamic and Undergo Structural Evolution Driven by Thermodynamic Control

Environmental factors, such as mechanical stress and/or polyanions, play an important role in promoting the thermodynamic stability of otherwise dynamic tau fibrils, and it is speculated that, in patients, such factors might contribute to the maturation of disease-specific conformers.

Wyatt C. Powell, Nicholas L. Yan, Eric Tse et al. · 0 citations
Open access Aug 2026

A pathological phosphorylation pattern enhances tau cooperativity on microtubules and facilitates tau filament assembly

Investigating how differential phosphorylation affects microtubule binding, cooperative tau envelope formation, and NFT-relevant filament assembly finds that phosphorylation more dramatically impacts cooperativity between tau molecules during envelope formation.

Xiangyu Fan, Joey B. Truong, Kyoko Okada et al. · 0 citations
Open access Sep 2026

A water-pinning hotspot drives templated tau aggregation

Tau assembles into fibrillar aggregates that are pathological hallmarks of a group of neurodegenerative diseases collectively called tauopathies. Templated aggregation of naïve tau to seeding-competent fibrils that proceed from cell to cell is a key driver of prion-like progression of tauopathies. This study tests the...

Chung-Ta Han, Karen Tsay, Samuel Lobo et al. · 0 citations
#protein folding Review Open access Sep 2026

From dynamic condensates to pathological assemblies: the phase behavior of tau and α-synuclein

Neurons rely on precise protein folding, trafficking, and turnover to maintain synaptic function. Disruption of proteostasis promotes misfolded proteins that impair axonal transport, mitochondrial function, and signalling, contributing to neuronal loss. Although neurodegeneration has traditionally focused on stable amy...

Suelen Camargo, Kevin Novelo, Scott D. Ryan · 0 citations
Open access Sep 2026

Structural heterogeneity of CTE Type I tau filaments with an interface-shifted polymorph

Tau filament types can differ in inter-protofilament packing while sharing the same protofilament fold. Motivated by our recent findings in vacuolar tauopathy, we analyzed cryo-electron microscopy (cryo-EM) data from brain-derived chronic traumatic encephalopathy (CTE) tau filaments deposited in EMPIAR-10313. We resolv...

Ryohei Watanabe, Edward B. Lee · 0 citations
Aug 2026

Captopril Enables the Inhibition of tRNA-Mediated Tau Aggregation.

Using in vitro reconstitution and high-resolution imaging, tRNA is identified as a major inducer of tau aberrant aggregation and captopril effectively inhibits both general and tRNA-induced tau aggregation, positioning CAP as a potential therapeutic candidate.

Bo-Ru Peng, Quan Deng, Xiao-Hua Zhu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.